Navigation Links
Japanese Researchers Develop New Smallpox Vaccine
Date:3/10/2009

No serious side effects are found in latest test, study reports,,

TUESDAY, March 10 (HealthDay News) -- A third-generation tissue-cultured smallpox vaccine shows promise, Japanese researchers report.

"The threat of smallpox bioterrorism has prompted reconsideration of the need for smallpox vaccination," the researchers noted. "Serious events associated with first-generation vaccines #133; have raised obstacles to vaccination campaigns in the United States."

Second-generation vaccines also cause a high rate of serious side effects, they said.

"Developing a vaccine that is safer than first-generation vaccines yet highly immunogenic [producing immunity or an immune response] is crucial to constructing a prevention plan in the event of bioterrorist attack," they added.

The researchers studied the clinical and immunological responses to the LC16m8 vaccine in 1,692 adults who had previously been vaccinated against smallpox and 1,529 adults who had not been vaccinated. LC16m8 is a live, attenuated (reduced in strength) vaccine.

Participants were examined 10 to 14 days after being vaccinated. The researchers found that antibodies developed in about 90 percent of those who had not been previously vaccinated, and an effective booster response occurred in 60 percent of those who had previously been vaccinated. None of the participants suffered serious side effects.

The study "offers supported evidence for the safety of LC16m8 vaccine in adults," wrote Dr. Tomoya Saito, of Keio University in Tokyo, and his colleagues."LC16m8 vaccine appears to be a viable alternative to first-, second- and other third-generation vaccines in a smallpox [bioterrorism] preparedness program."

The study appears in the March 11 issue of the Journal of the American Medical Association.

More information

The U.S. Centers for Disease Control and Prevention has more about smallpox.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, March 10, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
2. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
3. Chemo Drug Improves Stomach Cancer Survival for Japanese Patients
4. SNM/Nihon Medi-Physics sponsor new fellowship program for Japanese physicians
5. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
6. Nihon LocalSoft Designs New Japanese Software for IRadimed Corporations Award-Winning MRidium MRI Infusion System
7. Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market
8. Health and Beauty Come Full Circle: Chado-En Brings Full Benefit of Japanese Green Tea to Spas
9. Japanese encephalitis virus causes double trouble to brain
10. Fondness for Fish Keeps Japanese Hearts Healthy
11. First Implant of DuraHeart(TM) Left Ventricular Assist System (LVAS) in Japanese Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Japanese Researchers Develop New Smallpox Vaccine
(Date:1/16/2017)... OR (PRWEB) , ... January 16, 2017 , ... ... author, editor, attorney, science teacher, http://www.ageofautism.com/legal , Sharon Kleyne, America’s leading ... Kent Heckenlively to her nationally syndicated radio program, The Sharon Kleyne Hour Power ...
(Date:1/16/2017)... IL (PRWEB) , ... January 16, 2017 , ... ... (iaedp) organized to provide first-quality education and high-level training standards to an international ... spectrum of eating disorder problems. As a way to further its mission at ...
(Date:1/16/2017)... ... January 16, 2017 , ... San Francisco dentist, Dr. ... the latest in 3-D scanning device which is capable of taking digital impressions of ... in dentistry, such as CAD CAM restorations , in terms of speed, efficiency ...
(Date:1/16/2017)... , ... January 16, 2017 , ... NexTec Group has ... group of 100 organizations honored for their accomplishments in the field of midmarket financial ... industry leadership and recognition, and innovation. Selection is not based on revenue and those ...
(Date:1/15/2017)... CINCINNATI, Ohio (PRWEB) , ... January 15, 2017 ... ... their applications, Gensuite’s Community Outreach is a program that strives to better communities ... in each global locations’ community. It also provides the opportunity for team members ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... , Jan. 14, 2017  Johnson & Weaver, LLP ... of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ... through October 31, 2016 (the "Class Period"). Zimmer ... and markets orthopaedic reconstructive products, such as knee and hip ... ...
(Date:1/13/2017)... , January 13, 2017 Constant research ... AIDS will collectively contribute to the demand for western blotting ... a value of US$ 551.0 Mn by 2016 end. Developing ... the most lucrative markets for western blotting, whereas ... globally. ...
(Date:1/13/2017)... YORK , January 13, 2017 ... equities to see how they have fared at yesterday,s ... ), Galena Biopharma Inc. (NASDAQ: GALE ), ... These companies harness cellular and biomolecular processes to develop ... reduce our environmental footprint, feed the hungry, use less ...
Breaking Medicine Technology: